Cargando…

Utilization of short-course radiation therapy for patients with nonmetastatic rectal adenocarcinoma in the United States

PURPOSE: Preoperative short-course radiation therapy (SCRT) for patients with nonmetastatic rectal adenocarcinoma has been studied in European trials, but is not often used in the United States. We aim to describe the utilization of preoperative SCRT among patients with nonmetastatic rectal cancer i...

Descripción completa

Detalles Bibliográficos
Autores principales: Abdel-Rahman, Omar, Elhalawani, Hesham M., Allen, Pamela K., Holliday, Emma B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6200897/
https://www.ncbi.nlm.nih.gov/pubmed/30370362
http://dx.doi.org/10.1016/j.adro.2018.07.007
_version_ 1783365419420090368
author Abdel-Rahman, Omar
Elhalawani, Hesham M.
Allen, Pamela K.
Holliday, Emma B.
author_facet Abdel-Rahman, Omar
Elhalawani, Hesham M.
Allen, Pamela K.
Holliday, Emma B.
author_sort Abdel-Rahman, Omar
collection PubMed
description PURPOSE: Preoperative short-course radiation therapy (SCRT) for patients with nonmetastatic rectal adenocarcinoma has been studied in European trials, but is not often used in the United States. We aim to describe the utilization of preoperative SCRT among patients with nonmetastatic rectal cancer in the National Cancer Database and describe factors associated with its use. METHODS AND MATERIALS: The National Cancer Database was queried for patients treated with preoperative radiation therapy followed by surgery for nonmetastatic rectal adenocarcinoma between 2004 and 2014. Patient, tumor, and treatment-related characteristics were compared between patients treated with SCRT (20-25 Gy in <7 fractions) and patients treated with long-course radiation therapy (45-70 Gy in ≥ 25 fractions). Univariate and multivariate Cox regression analyses were used to evaluate factors associated with overall survival. Survival rates were compared using an inverse-probability-weighted regression adjustment method. RESULTS: A total of 42,336 patients were included for analysis of which 41,867 patients (98.9%) were treated with long-course radiation therapy and 469 patients (1.1%) with SCRT. Patients treated with SCRT were older, had more comorbidities, had earlier T-stage, and were more likely to be clinically node-negative. Patients treated with SCRT were more likely to be treated at an academic center, have Medicare insurance, and be treated without chemotherapy. Patients treated with SCRT had lower pathological complete response rates (4.3% vs 6.9%; P < .001) and higher rates of positive circumferential resection margins (8.3% vs 5.2%; P = .001). On multivariate analysis, radiation fractionation was not significantly associated with overall survival. CONCLUSIONS: SCRT is used for only approximately 1% of patients treated preoperatively for nonmetastatic rectal cancer in the United States. The results of recently completed randomized trials may further inform patterns of practice in the United States and abroad.
format Online
Article
Text
id pubmed-6200897
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-62008972018-10-26 Utilization of short-course radiation therapy for patients with nonmetastatic rectal adenocarcinoma in the United States Abdel-Rahman, Omar Elhalawani, Hesham M. Allen, Pamela K. Holliday, Emma B. Adv Radiat Oncol Gastrointestinal Cancer PURPOSE: Preoperative short-course radiation therapy (SCRT) for patients with nonmetastatic rectal adenocarcinoma has been studied in European trials, but is not often used in the United States. We aim to describe the utilization of preoperative SCRT among patients with nonmetastatic rectal cancer in the National Cancer Database and describe factors associated with its use. METHODS AND MATERIALS: The National Cancer Database was queried for patients treated with preoperative radiation therapy followed by surgery for nonmetastatic rectal adenocarcinoma between 2004 and 2014. Patient, tumor, and treatment-related characteristics were compared between patients treated with SCRT (20-25 Gy in <7 fractions) and patients treated with long-course radiation therapy (45-70 Gy in ≥ 25 fractions). Univariate and multivariate Cox regression analyses were used to evaluate factors associated with overall survival. Survival rates were compared using an inverse-probability-weighted regression adjustment method. RESULTS: A total of 42,336 patients were included for analysis of which 41,867 patients (98.9%) were treated with long-course radiation therapy and 469 patients (1.1%) with SCRT. Patients treated with SCRT were older, had more comorbidities, had earlier T-stage, and were more likely to be clinically node-negative. Patients treated with SCRT were more likely to be treated at an academic center, have Medicare insurance, and be treated without chemotherapy. Patients treated with SCRT had lower pathological complete response rates (4.3% vs 6.9%; P < .001) and higher rates of positive circumferential resection margins (8.3% vs 5.2%; P = .001). On multivariate analysis, radiation fractionation was not significantly associated with overall survival. CONCLUSIONS: SCRT is used for only approximately 1% of patients treated preoperatively for nonmetastatic rectal cancer in the United States. The results of recently completed randomized trials may further inform patterns of practice in the United States and abroad. Elsevier 2018-08-06 /pmc/articles/PMC6200897/ /pubmed/30370362 http://dx.doi.org/10.1016/j.adro.2018.07.007 Text en © 2018 The Authors on behalf of the American Society for Radiation Oncology http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Gastrointestinal Cancer
Abdel-Rahman, Omar
Elhalawani, Hesham M.
Allen, Pamela K.
Holliday, Emma B.
Utilization of short-course radiation therapy for patients with nonmetastatic rectal adenocarcinoma in the United States
title Utilization of short-course radiation therapy for patients with nonmetastatic rectal adenocarcinoma in the United States
title_full Utilization of short-course radiation therapy for patients with nonmetastatic rectal adenocarcinoma in the United States
title_fullStr Utilization of short-course radiation therapy for patients with nonmetastatic rectal adenocarcinoma in the United States
title_full_unstemmed Utilization of short-course radiation therapy for patients with nonmetastatic rectal adenocarcinoma in the United States
title_short Utilization of short-course radiation therapy for patients with nonmetastatic rectal adenocarcinoma in the United States
title_sort utilization of short-course radiation therapy for patients with nonmetastatic rectal adenocarcinoma in the united states
topic Gastrointestinal Cancer
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6200897/
https://www.ncbi.nlm.nih.gov/pubmed/30370362
http://dx.doi.org/10.1016/j.adro.2018.07.007
work_keys_str_mv AT abdelrahmanomar utilizationofshortcourseradiationtherapyforpatientswithnonmetastaticrectaladenocarcinomaintheunitedstates
AT elhalawaniheshamm utilizationofshortcourseradiationtherapyforpatientswithnonmetastaticrectaladenocarcinomaintheunitedstates
AT allenpamelak utilizationofshortcourseradiationtherapyforpatientswithnonmetastaticrectaladenocarcinomaintheunitedstates
AT hollidayemmab utilizationofshortcourseradiationtherapyforpatientswithnonmetastaticrectaladenocarcinomaintheunitedstates